Filtered By:
Countries: Saudi Arabia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4523 results found since Jan 2013.
Renin-angiotensin-system blockers and IgG antibodies in end-stage renal disease hemodialysis-receiving patients diagnosed with COVID-19 infection
CONCLUSION: More studies are required to assess whether patients with a SARS-CoV-2 infection that do not have an indication for being prescribed ACEIs/ARBs would benefit from receiving these medications.PMID:37717960 | DOI:10.15537/smj.2023.44.9.20230129
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Sultan A Almdallaleh Abdulkareem O Alsuwaida Abdulhadi M Altalhi Dina M ALJayar Elzibair E Massad Mazaher M Hamid Parameaswari P Jaganathan Fadel H Al-Hababi Source Type: research
COVID-19 vaccine in hemodialysis patients: Time for a boost
CONCLUSION: The results show a dose-dependent association between IgG antibody levels and the number COVID-19 vaccines received. The study highlights the need for booster COVID-19 vaccination for patients on hemodialysis.PMID:37717958 | DOI:10.15537/smj.2023.44.9.20230285
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Waleed H Mahallawi Source Type: research
Renin-angiotensin-system blockers and IgG antibodies in end-stage renal disease hemodialysis-receiving patients diagnosed with COVID-19 infection
CONCLUSION: More studies are required to assess whether patients with a SARS-CoV-2 infection that do not have an indication for being prescribed ACEIs/ARBs would benefit from receiving these medications.PMID:37717960 | DOI:10.15537/smj.2023.44.9.20230129
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Sultan A Almdallaleh Abdulkareem O Alsuwaida Abdulhadi M Altalhi Dina M ALJayar Elzibair E Massad Mazaher M Hamid Parameaswari P Jaganathan Fadel H Al-Hababi Source Type: research
COVID-19 vaccine in hemodialysis patients: Time for a boost
CONCLUSION: The results show a dose-dependent association between IgG antibody levels and the number COVID-19 vaccines received. The study highlights the need for booster COVID-19 vaccination for patients on hemodialysis.PMID:37717958 | DOI:10.15537/smj.2023.44.9.20230285
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Waleed H Mahallawi Source Type: research
Renin-angiotensin-system blockers and IgG antibodies in end-stage renal disease hemodialysis-receiving patients diagnosed with COVID-19 infection
CONCLUSION: More studies are required to assess whether patients with a SARS-CoV-2 infection that do not have an indication for being prescribed ACEIs/ARBs would benefit from receiving these medications.PMID:37717960 | DOI:10.15537/smj.2023.44.9.20230129
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Sultan A Almdallaleh Abdulkareem O Alsuwaida Abdulhadi M Altalhi Dina M ALJayar Elzibair E Massad Mazaher M Hamid Parameaswari P Jaganathan Fadel H Al-Hababi Source Type: research
COVID-19 vaccine in hemodialysis patients: Time for a boost
CONCLUSION: The results show a dose-dependent association between IgG antibody levels and the number COVID-19 vaccines received. The study highlights the need for booster COVID-19 vaccination for patients on hemodialysis.PMID:37717958 | DOI:10.15537/smj.2023.44.9.20230285
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Waleed H Mahallawi Source Type: research
The impact of COVID-19 related lockdown restrictions on musculoskeletal health: a systematic review
This study was aimed to synthesis literature that assessed the impact of COVID-19 related lockdown restrictions on MSK health. A literature search was conducted using MEDLINE, CINAHL, PsycINFO, Allied and Complementary Medicine Database (AMED), Web of Science, and Scopus databases. Studies meeting the following criteria were included in the review: the condition being considered was MSK health, the intervention was COVID-19 related lockdown restrictions, cross sectional studies, cohort studies, case controlled, prospective studies and retrospective studies. Data were extracted by 2 independent researchers. Risk of bias was...
Source: Rheumatology International - September 12, 2023 Category: Rheumatology Source Type: research
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.ABSTRACTThe severity of the 2019 coronavirus disease (COVID-19) and its effects remain unpredictable. Certain factors, such as obesity, hypertension, and type 2 diabetes mellitus, may increase the severity of the disease. Rheumatology experts suggest that patients with active autoimmune conditions and controlled autoimmune diseases on immunosuppressive therapy may be at higher risk of developing severe COVID-19. In this retrospective observational study, we aimed to examine the patterns of COVID-19 in patients with underlying rheumatological diseases and their...
Source: Journal of Medicine and Life - September 7, 2023 Category: General Medicine Authors: Safi Alqatari Ameera Nemer Manal Hasan Raed Bukhari Reem Al Argan Dania Al Khafaji Abrar Alwaheed Alaa Alzaki Marwan Al-Wazza Sara Al Warthan Abir Al Saeed Feda Albeladi Hashim Almeer Reem AlSulaiman Ahmed Abu Quren Source Type: research
